Transport and metabolism of (±)-praeruptorin A in Caco-2 cell monolayers

被引:22
作者
Jing, W. H. [1 ]
Song, Y. L. [1 ]
Yan, R. [1 ]
Bi, H. C. [1 ,2 ]
Li, P. T. [3 ]
Wang, Y. T. [1 ,4 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, Taipa, Peoples R China
[2] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, Guangzhou 510275, Guangdong, Peoples R China
[3] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China
[4] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China
关键词
INTESTINAL-ABSORPTION; GENE-EXPRESSION; DRUG TRANSPORT; HUMAN LIVER; PERMEABILITY; CARBOXYLESTERASES; ENANTIOMERS; ESTER;
D O I
10.3109/00498254.2010.526653
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
(+/-)-Praeruptorin A (dl-PA) is one of the main pyranocoumarins of Peucedani Radix and the chemical marker for quality control of the herb in China. This study investigated the transport and metabolism of dl-PA, for the first time, in Caco-2 cell monolayers. PA enantiomers of dl-PA in the transport study were simultaneously determined using a simple and rapid enantio-selective high performance liquid chromatography-UV method. Both dextrorotatory (d-PA) and levorotatory (l-PA) enantiomers traversed Caco-2 monolayer rapidly in both directions (absorptive P-app: 2.01-3.03 x 10<SU-5</SU cm/s; secretory P-app: 1.58-1.96 x 10<SU-5</SU cm/s) mainly via passive diffusion. Higher transport rates of dPA were observed in both directions. PA enantiomers were incompletely recovered after the transport study. Nonspecific binding to the Transwell inserts, irreversible binding to cellular components and metabolism within the cells accounted for the loss. dl-PA was partially hydrolyzed in Caco-2 monolayers and yielded two stereoisomers via removal of the acetyl group from C-4' position. Both phenylmethylsulphonyl fluoride (a nonspecific esterase inhibitor) and bis(p-nitrophenyl) phosphate sodium salt (a specific inhibitor of carboxylesterases) completely abolished dl-PA hydrolysis. In summary, PA enantiomers were rapidly transported across Caco-2 cells and partially hydrolyzed by carboxylesterases during permeation. These findings provide mechanistic understanding of in vivo pharmacokinetic properties of dl-PA.
引用
收藏
页码:71 / 81
页数:11
相关论文
共 32 条
  • [11] Transport characteristics of fexofenadine in the Caco-2 cell model
    Petri, N
    Tannergren, C
    Rungstad, D
    Lennernäs, H
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (08) : 1398 - 1404
  • [12] Rao Man-ten, 2002, Yaoxue Xuebao, V37, P401
  • [13] Characterization of Metabolism and in Vitro Permeability Study of Notoginsenoside R1 from Radix Notoginseng
    Ruan, Jian-Qing
    Leong, Weng-Im
    Yan, Ru
    Wang, Yi-Tao
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2010, 58 (09) : 5770 - 5776
  • [14] *STAT PHARM COMM P, 2010, PHARM PEOPL REP CHIN, V1, P187
  • [15] Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs
    Sun, DX
    Lennernas, H
    Welage, LS
    Barnett, JL
    Landowski, CP
    Foster, D
    Fleisher, D
    Lee, KD
    Amidon, GL
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (10) : 1400 - 1416
  • [16] Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine
    Suzuki, H
    Sugiyama, Y
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) : 3 - 12
  • [17] Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164
  • [18] Takai S, 1997, BIOL PHARM BULL, V20, P869
  • [19] Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol
    Tang, Man
    Mukundan, Madhu
    Yang, Jian
    Charpentier, Nathan
    LeCluyse, Edward L.
    Black, Chris
    Yang, Dongfang
    Shi, Deshi
    Yan, Bingfang
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) : 1467 - 1476
  • [20] Characterization of mefenamic acid-guaiacol ester: Stability and transport across Caco-2 cell monolayers
    Tantishaiyakul, V
    Wiwattanawongsa, K
    Pinsuwan, S
    Kasiwong, S
    Phadoongsombut, N
    Kaewnopparat, S
    Kaewnopparat, N
    Rojanasakul, Y
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 1013 - 1018